Fairly healthy men older than 80 achieved much the same outcomes with chemo as younger men

[JimJimJimJim]

Jim Marshall (not a doctor) said ...

Otherwise fairly healthy men older than 80 achieved much the same outcomes with Taxotere (docetaxel) chemotherapy, either on a 3 weekly or a 1 weekly dose, as younger men.

... end Jim

 

This abstract is only available for 24 hours for members to get an email.
After 24 hours the abstract will only be available through the link to the ASCO site below.

 

Clinical outcome (CO) evaluation of very old (≥ 80 years) castration resistant prostate cancer (CRPC) patients (pts) treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (DELPHI study).

 

...

 

Caution
This extract was published in association with the American Society of Clinical Oncology 2013 annual conference. Though the research behind it may have been excellent, your doctor cannot yet give much weight to it for a number of reasons, including:

• It is only an extract. The full paper may reveal information important for your treatment.
• The study has not yet had peer review - with doctors and researchers scrutinising the study closely for mistakes and limitations after it is published in a professional journal.
•  Your doctor may already be aware of a limitations of the findings because of their wider reading.

The link below is to a page or document that we do not control.
Parts of it may be wrong or misleading.
Check with your doctor if something interests you.
If it is temporarily or permanently unavailable, you may receive an error message.

 

Source URL: http://meetinglibrary.asco.org/content/112751-132